Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |